10 Things Worth Pay...
Carlisle Companies Inc. (CSL: NYSE)
$48.69 -1.12 | -2.25%
06/04/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 15.20 | 73.80 | 17.70 |
| P/E High - Last 5 Yrs | 44.50 | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | 7.60 | n.a. | 12.50 |
| Beta | 1.12 | 1.65 | 0.98 |
| Price to Sales (TTM) | 0.90 | 0.32 | 1.42 |
| Price to Book (MRQ) | 1.98 | 2.30 | 2.41 |
| Price to Tangible Book (MRQ) | 14.84 | 5.87 | 5.08 |
| Price to Cash Flow (TTM) | 10.40 | 7.60 | 9.80 |
| Price to Free Cash Flow (TTM) | -10.00 | -77.80 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 1.40 | 2.00 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | 2.00 | 1.20 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | 5.47 | -11.06 | -0.76 |
| Payout Ratio (TTM) | 22.00 | 23.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 28.20 | 21.20 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 27.60 | 6.00 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 2.09 | -3.05 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | 79.60 | 21.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | 79.60 | 21.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | -2.38 | -13.33 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 24.30 | -3.56 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 1.00 | 1.00 | 1.10 |
| Current Ratio (MRQ) | 2.00 | 1.80 | 1.60 |
| LT Debt to Equity (MRQ) | 0.39 | 1.38 | 0.82 |
| Total Debt to Equity (MRQ) | 0.49 | 1.58 | 0.96 |
| Interest Coverage (TTM) | 13.80 | 2.50 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 24.40 | 21.10 | 46.90 |
| Gross Margin - 5 Yr Avg | 23.10 | 20.80 | 47.70 |
| EBITD Margin (TTM) | 11.80 | 8.60 | 18.90 |
| EBITD - 5 Yr Avg | 10.86 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 8.60 | 2.20 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 8.40 | 1.50 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.06 | 0.01 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 5.30 | 0.60 | 7.00 |
| Return on Assets (TTM) | 6.40 | 1.50 | 3.10 |
| Return on Assets - 5 Yr Avg | 6.40 | 0.70 | 2.50 |
| Return on Investment (TTM) | 9.60 | 3.50 | 7.90 |
| Return on Investment - 5 Yr Avg | 9.30 | 1.60 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 310,927.00 | 245,491.00 | 449,376.00 |
| Net Income/Employee (TTM) | 18,809.00 | 3,054.00 | 39,003.00 |
| Receivable Turnover (TTM) | 6.70 | 6.70 | 7.60 |
| Inventory Turnover (TTM) | 5.20 | 5.20 | 8.30 |
| Asset Turnover (TTM) | 1.20 | 1.30 | 0.40 |
Portfolios with CSL
- Portfolio NameUser Type
- ContributorTop-Rated Industrial Conglo...
- ContributorDividend Stocks for the Wee...
- UserTop Dividend Increasers for...
- Usermarkinhi Portfolio 1
- UserCGIC
- Userazhester Portfolio 1
- UserRich's Gems
- UserBarron's Interview With Nic...
- Userc bgvm 1848
- UserStreet Legal
Latest CSL Headlines from TheStreet
- Carlisle Companies Stock To Go Ex-dividend Monday (CSL) 05.18.12 | 10:05 am
- Ex-Dividend Stocks: Valero Energy, Mattel 05.18.12 | 05:05 am
- Carlisle Companies Reaches New 52-Week High (CSL) 05.01.12 | 02:05 pm
- Analysts' Actions: AAPL, AXE, PNRA, DD 04.25.12 | 08:04 am
- Carlisle Companies' CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.24.12 | 02:04 pm
- Carlisle Companies Stock Gaps Up On Today's Open (CSL) 04.24.12 | 10:04 am
- Carlisle Companies Reaches New 52-Week High (CSL) 04.02.12 | 11:04 am
- Carlisle Companies Stock Hits New 52-Week High (CSL) 03.13.12 | 05:03 pm
- Carlisle Companies Reaches New 52-Week High (CSL) 02.21.12 | 11:02 am
- Carlisle Companies Stock To Go Ex-dividend Tomorrow (CSL) 02.14.12 | 08:02 am
Press Releases for CSL
- CSL Behring Announces FDA Filing Of Biologics License Application For 4-Factor PCC For Urgent Reversal Of Vitamin K Antagonist Anticoagulant Therapy - PR Newswire 05.29.12 | 02:05 pm
- Carlisle Companies To Present At KeyBanc Capital Markets Conference May 30 - Business Wire 05.29.12 | 09:05 am
- Carlisle Construction Materials To Add PVC Manufacturing - PR Newswire 05.22.12 | 03:05 pm
- Carlisle Companies To Present At Oppenheimer’s Industrials Conference May 16 - Business Wire 05.15.12 | 09:05 am
- CSL Behring Initiates Study Of Subcutaneous Administration Of C1-esterase Inhibitor In Patients With Hereditary Angioedema - PR Newswire 05.03.12 | 03:05 pm
- Carlisle Companies Declares Regular Quarterly Dividend - Business Wire 05.02.12 | 10:05 am
- Carlisle Companies To Announce 1st Quarter 2012 Earnings On April 24 - Business Wire 04.02.12 | 09:04 am
- CSL Behring Commences Phase I Study With RVIIa-FP, A Novel Therapy To Treat People With Hemophilia A And Hemophilia B Who Have Inhibitors - PR Newswire 03.30.12 | 02:03 pm
- First Patient Enrolled In CSL Behring PATH Trial To Evaluate Immune Globulin Subcutaneous (Human) 20% Liquid, Hizentra®, In The Treatment Of CIDP - PR Newswire 03.26.12 | 10:03 am
- Carlisle Companies To Present At Sidoti’s Institutional Investor Forum On March 20 - Business Wire 03.19.12 | 09:03 am
Partner Headlines for CSL
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 01.25.12 | 09:01 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 01.19.12 | 09:01 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 01.12.12 | 09:01 am
- 3 Dividend Plays From The Rubber And Plastics Industry - Seeking Alpha 11.06.11 | 08:11 am
- 3M Company Earnings Preview: Analysts Expect Higher EPS, Revenue - Benzinga 10.20.11 | 01:10 pm
- Carlisle Companies - Value - Zacks 06.08.11 | 01:06 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 05.05.11 | 09:05 am
- UPDATE 1-Carlisle net drops on charges, raw material costs - Reuters 02.07.11 | 07:02 am
- Carlisle Companies - Value - Zacks 01.14.11 | 01:01 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 01.05.11 | 09:01 am





